SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 48 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $227,000 | -27.7% | 94,000 | -41.2% | 0.00% | -25.0% |
Q2 2014 | $314,000 | +15.9% | 160,000 | 0.0% | 0.00% | +33.3% |
Q1 2014 | $271,000 | +13.4% | 160,000 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $239,000 | -75.3% | 160,000 | -79.7% | 0.00% | -76.9% |
Q3 2013 | $969,000 | +2.8% | 790,000 | 0.0% | 0.01% | 0.0% |
Q2 2013 | $943,000 | – | 790,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GRACE BROTHERS MANAGEMENT LLC | 2,800,000 | $5,117,000 | 4.90% |
SILVERBACK ASSET MANAGEMENT LLC | 18,209,000 | $33,322,000 | 4.30% |
RAVEN ROCK CAPITAL MANAGEMENT, LLC | 1,000,000 | $1,990,000 | 2.80% |
Verition Fund Management LLC | 5,504,000 | $10,062,000 | 2.26% |
CAMDEN ASSET MANAGEMENT L P /CA | 26,798,000 | $48,856,000 | 1.81% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,600,000 | $15,679,000 | 1.60% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 3,000,000 | $5,490,000 | 1.46% |
BASSO CAPITAL MANAGEMENT, L.P. | 4,825,000 | $8,782,000 | 1.40% |
Wellesley Asset Management | 12,564 | $23,006,000 | 1.35% |
WOLVERINE ASSET MANAGEMENT LLC | 31,156,000 | $56,979,000 | 1.11% |